Bristol-Myers Squibb to sell Otezla to Amgen for $13.4B
Update: 2025-09-23
Description
Bristol-Myers Squibb to sell Otezla to Amgen for $13.4B Bristol-Myers Squibb's sale of psoriasis drug Otelza to Amgen for $13.4 billion........ is a figure that's close to Morningstar's fair value estimate for the drug.We don't expect any major impacts to our fair value estimates or moats for either....
This item belongs to: audio/rivet360-audio-collection.
This item has files of the following types: Archive BitTorrent, Metadata, VBR MP3
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
